image
IGM Biosciences, Inc. IGMS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.47
-6.24 %
$ 563 M
Market Cap
-2.62
P/E
INCOME STATEMENT
2.13 M REVENUE
99.25%
Growth Rates
1Year 99.25%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-263 M OPERATING INCOME
-15.58%
Growth Rates
1Year -15.58%
3Years -46.80%
5Years -63.15%
7Years 0.00%
10Years 0.00%
-246 M NET INCOME
-11.45%
Growth Rates
1Year -11.45%
3Years -44.69%
5Years -61.10%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall IGM Biosciences, Inc.
image
Revenue 2.13 M
Cost Of Revenue 214 M
Gross Profit -212 M
Operating Expenses 266 M
Operating Income -263 M
Other Expenses -17 M
Net Income -246 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 2.1 1.1 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 213.8 10.6 7.7 3.6 2.3 0.3 0.2
Gross Profit (211.7) (9.5) (7.7) (3.6) (2.3) (0.3) (0.2)
OPERATING INCOME
Operating Expenses 265.6 229.0 165.3 83.3 44.5 22.8 11.1
Selling, General and Administrative Expenses 50.1 49.7 38.3 18.2 9.2 3.8 2.5
Research and Development Expenses 215.5 179.3 127.0 65.0 35.3 19.0 8.6
Operating Income (263.5) (228.0) (165.3) (83.3) (44.5) (22.8) (11.1)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 0
Total Other Income 17.7 6.9 0.2 1.9 1.4 80 K 93 K
Pre-Tax Income (245.7) (221.1) (165.2) (81.4) (43.1) (22.7) (11.1)
NET INCOME
Tax Provision 0.7 (6.9) (4.5) (1.0) (0.6) 80 K 0
Net Income (246.4) (214.2) (160.7) (80.3) (42.5) (22.7) (11.1)
EPS 4.71 5.16 4.8 2.61 4.73 51.8 25.2